Zhao-Peng Liu (Zhaopeng Liu)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 7

Top Venues

Organic letters

ChemMedChem

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

山东大学

This page only lists publications with an associated author ORCID identifier.

Affiliation History

山东大学 Apr 01 2005

China

教授 :: 药学院药物化学研究所

Publications

Ali K Alshabrawy, Yingjie Cui, Cyan Sylvester, Dongqing Yang, Emilio S Petito, Kate R Barratt, Rebecca K Sawyer, Jessica K Heatlie, Ruhi Polara, Matthew J Sykes, Gerald J Atkins, Shane M Hickey, Michael D Wiese, Andrea M Stringer, Zhao-Peng Liu, Paul H Anderson
Therapeutic Potential of a Novel Vitamin D 3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules 12 (7) (2022)
Li Chen, Zhao-Peng Liu, Xun Li
Recent Advances in Dual BRD4-Kinase Inhibitors Based on Polypharmacology. ChemMedChem 17 (6) (2022)
Chenchen Ma, Peng Liu, Siyuan Cui, Chang Gao, Xing Tan, Zhao-Peng Liu, Rui-Rong Xu
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside. Molecules (Basel, Switzerland) 27 (18) (2022)
Yasheng Zhu, Hongliang Wang, Gang Wang, Zehua Wang, Zhao-Peng Liu, Lei Liu
Enantioselective Construction of Single and Vicinal All-Carbon Quaternary Stereocenters through Ion-Pair-Catalyzed 1,6-Conjugate Addition. Organic letters 23 (18) (2021)
Ying-Jie Cui, Chao Liu, Chen-Chen Ma, Ya-Ting Ji, Yi-Li Yao, Long-Qian Tang, Cheng-Mei Zhang, Jing-De Wu, Zhao-Peng Liu
SAR Investigation and Discovery of Water-Soluble 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazoles as Potent Tubulin Polymerization Inhibitors. Journal of medicinal chemistry 63 (23) (2020)
Xiao-Long Shi, Ning Yan, Ying-Jie Cui, Zhao-Peng Liu
A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth. Cells 9 (3) (2020)
Jing-De Wu, Ying-Jie Cui, Yi-Gang Zhou, Long-Qian Tang, Cheng-Mei Zhang, Zhao-Peng Liu
Tubulin colchicine site binding agent LL01 displays potent antitumor efficiency both in vitro and in vivo with suitable drug-like properties. Investigational new drugs 38 (1) (2019)

Zhao-Peng Liu.css-eqlu8i{font-size:small;padding-left:4px;} (Zhaopeng Liu)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhao-Peng Liu (Zhaopeng Liu)